World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
49963
World Ranking
1947
National Ranking
952

Medicine

D-Index
75
Citations
49957
World Ranking
18955
National Ranking
9450

Lionel Apetoh publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lionel Apetoh sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 162 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lionel Apetoh D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lionel Apetoh sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 75 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lionel Apetoh is affiliated with Indiana University in the United States. Their research spans multiple areas within medical science, with a strong emphasis on immunology and oncology.

Their work is primarily situated within the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Subfields of interest include Immunology, Oncology, Molecular Biology, Cancer Research, and Pharmacology.

Their research topics focus on diverse aspects of immune function and cancer biology, including:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer, Lipids, and Metabolism
  • Interferon and immune responses

Frequent coauthors of Lionel Apetoh include:

  • Sayyed Hamed Shahoei
  • Erik R. Nelson
  • Frédérique Végran
  • Liqian Ma
  • Élise Jacquin

The scientist has published extensively in several journals, with frequent contributions to:

  • Cancer Immunology Research
  • Nature
  • Cell Reports
  • Journal for ImmunoTherapy of Cancer
  • Cancer Letters

Representative recent publications include:

  • "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)," 2021, published in Autophagy
  • "B-cell-specific checkpoint molecules that regulate anti-tumour immunity," 2023, published in Nature
  • "An IL-27-Driven Transcriptional Network Identifies Regulators of IL-10 Expression across T Helper Cell Subsets," 2020, published in Cell Reports
  • "CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells," 2022, published in Journal for ImmunoTherapy of Cancer
  • "Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors," 2022, published in Cell Death and Disease

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Calreticulin exposure dictates the immunogenicity of cancer cell death

    Michel Obeid;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;François Ghiringhelli;François Ghiringhelli;François Ghiringhelli;Gian Maria Fimia

  • Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid

  • Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

    Kaori Sakuishi;Lionel Apetoh;Jenna M. Sullivan;Bruce R. Blazar

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

    François Ghiringhelli;Lionel Apetoh;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Laetitia Aymeric;Laetitia Aymeric;Laetitia Aymeric

  • Immunological aspects of cancer chemotherapy.

    Laurence Zitvogel;Lionel Apetoh;Lionel Apetoh;François Ghiringhelli;Guido Kroemer;Guido Kroemer

  • 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

    Julie Vincent;Grégoire Mignot;Fanny Chalmin;Sylvain Ladoire

  • Immunogenic death of colon cancer cells treated with oxaliplatin.

    A. Tesniere;F. Schlemmer;F. Schlemmer;F. Schlemmer;V. Boige;O. Kepp;O. Kepp;O. Kepp

  • Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells

    Fanny Chalmin;Sylvain Ladoire;Grégoire Mignot;Julie Vincent

  • Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

    Romain Daillère;Romain Daillère;Romain Daillère;Marie Vétizou;Marie Vétizou;Marie Vétizou;Nadine Waldschmitt;Takahiro Yamazaki;Takahiro Yamazaki

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

    Mélanie Bruchard;Grégoire Mignot;Grégoire Mignot;Valentin Derangère;Valentin Derangère;Fanny Chalmin;Fanny Chalmin

  • The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27

    Lionel Apetoh;Francisco J Quintana;Caroline Pot;Nicole Joller

  • The anticancer immune response: indispensable for therapeutic success?

    Laurence Zitvogel;Lionel Apetoh;François Ghiringhelli;Fabrice André

  • The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.

    Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Alfredo Criollo;Alfredo Criollo;Alfredo Criollo

  • Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Federico Pietrocola;Federico Pietrocola;Jonathan Pol;Erika Vacchelli;Erika Vacchelli;Shuan Rao

  • Molecular characteristics of immunogenic cancer cell death.

    A Tesniere;T Panaretakis;T Panaretakis;T Panaretakis;O Kepp;O Kepp;O Kepp;L Apetoh;L Apetoh;L Apetoh

  • A novel dendritic cell subset involved in tumor immunosurveillance.

    Julien Taieb;Nathalie Chaput;Cédric Ménard;Lionel Apetoh

  • Radiotherapy and immunogenic cell death.

    Encouse B. Golden;Lionel Apetoh;Lionel Apetoh

Frequent Co-Authors

François Ghiringhelli
François Ghiringhelli Centre Georges François Leclerc
Guido Kroemer
Guido Kroemer Université Paris Cité
Antoine Tesniere
Antoine Tesniere Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Bernhard Ryffel
Bernhard Ryffel University of Orléans
Theocharis Panaretakis
Theocharis Panaretakis The University of Texas MD Anderson Cancer Center
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Yuting Ma
Yuting Ma University of Oxford
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Takahiro Yamazaki
Takahiro Yamazaki Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology often leads students to intersecting fields in healthcare, especially nursing. For those interested in complementing their immunology knowledge with clinical skills, pursuing an accelerated nursing degree can be a great option. Many candidates look for the easiest accelerated nursing programs to efficiently enter the workforce without compromising on quality education.

Similarly, aspiring nurses can start with easier admission options by enrolling in easy admission LPN programs. These pathways provide foundational clinical experience and are a practical stepping stone toward advanced roles in patient care.

For those aiming to advance further, nurse practitioner degrees are crucial, particularly for specialization in areas like immunology-related conditions. Identifying the easiest nurse practitioner program tailored to individual needs can greatly impact career progression and work-life balance.

Mental health is also deeply connected to immune system research, making Psychiatric Mental Health Nurse Practitioner (PMHNP) programs valuable. Prospective students should consider programs with strong clinical experiences, such as the best pmhnp programs online, which help bridge theory and practice effectively.

Best Scientists Citing Lionel Apetoh

Trending Scientists

Recently Published Articles